HeartBeat.bio

HeartBeat.bio is a Vienna-based biotechnology company focused on developing a high-throughput drug discovery platform for cardiovascular diseases. The company utilizes proprietary human cardiac organoids, known as Cardioids, which represent the first self-organizing 3D model that recapitulates the physiological architecture and function of the human heart chamber. This platform enables the screening of large compound libraries for efficacy and safety in a human-relevant system, significantly reducing the reliance on animal models and improving the predictability of clinical success. HeartBeat.bio targets major unmet needs in cardiology, including heart failure and various forms of cardiomyopathy, by identifying novel therapeutic targets and developing its own internal pipeline of drug candidates.